Apple Watch blood pressure tracking is one step closer to reality, after one of Apple's hardware partners reported successful trials of its sensor tech.
Health sensor company Rockley Photonics, which already lists Apple as a customer, has developed an infrared (IR) spectrophotometer-based sensor technology, which it says can monitor blood pressure non-invasively.
Essential reading: ECG smartwatches explained
It's has been conducting its own in-house pilot human study with a view to performing a larger study on the capabilities of the technology.
That pilot human study examined whether its laser-based approach and advanced algorithms could match up to the method that blood pressure monitoring wearables currently on the market adopt. The likes of the Samsung Galaxy Watch 4 use optical PPG sensors, but require calibration with a cuff monitor to offer reliable blood pressure monitor readings.
The Rockley pilot study featured 40 people using its photonics-based sensor, which was worn on the wrist by participants, and captured over 480 total measurements.
And according to the company, the results showed a strong correlation with control blood pressure readings from a cuff.
‚ÄúFollowing the recent success of our core body temperature studies, the results of our pilot blood pressure study using wrist-based measurement are extremely encouraging,‚ÄĚ said Dr. Hooman Abediasl, Senior Vice President of Product Engineering at Rockley.
‚ÄúThese positive results represent a huge step forward in validating our sensing solution and its ability to deliver powerful multi-biomarker functionality in a highly manufacturable wearable form factor.‚ÄĚ
Rockley, who already says it has contracts with big global manufacturers, including six of the top ten players in the wearable market, also believes it has the technology capable of measuring a host of other biomarkers including core body temperature, body hydration, alcohol, lactate, and glucose.
This blood pressure study, which was conducted with IRB approval by the WIRB-Copernicus Group Institutional Review Board (WCG IRB), also revealed that Rockley's photonics sensor also performed well when reading heart rate and heart rate variability, against electrocardiogram equipment.
Could a future Apple Watch be capable of non-invasively monitoring blood pressure?
If Rockley can match that stronger correlation with a traditional blood pressure monitor on a much larger scale study, then it would be pretty sizeable news for the wearable space.
Currently, Samsung smartwatches use the PPG optical sensor to take blood pressure readings but the sensor requires cuff calibration to offer accuracy on par with traditional monitors.
And the Huawei Watch D, which has just been released in China, actually uses air-filled cuffs that attach to the inside of the watch strap.
Taking the cuff calibration completely out of the equation would mark a major step for serious health monitoring from the wrist.
Delivering non-invasive blood pressure monitoring is definitely already on the agenda for a host of wearable makers. Both Fitbit (CTO, Eric Friedman interview) and Zepp Health (COO, Mike Yeung interview) have stated on record to Wareable that they‚Äôre pursuing the technology in the past.
Rockley's next steps will likely now be to expand on this initial study and look to explore how reliably they can track other promised biomarkers. We're sure the rest of the wearable world will be keeping a very close eye on its progress.